7 reports

Filgrastim is branded as Tevagrastim in EU and Granix in the US.

  • Opioid
  • Market Size
  • BioDelivery Sciences International, Inc.
  • ProStrakan Group plc
  • Teva Pharmaceuticals Ltd.
  • 5. All the trials included are unique trials.

The prominent features of this report are - ##.

  • Chronic Pain
  • Clinical Trial
  • Opioid
  • World
  • Pfizer Inc.
  • 5. ALL THE TRIALS INCLUDED ARE UNIQUE TRIALS.

THE PROMINENT FEATURES OF THIS REPORT ARE - ##.

  • Chronic Pain
  • Clinical Trial
  • Drug Discovery And Development
  • Opioid
  • Pfizer Inc.

THE PROMINENT FEATURES OF THIS REPORT ARE - ##.

  • Analgesic
  • Clinical Trial
  • Opioid
  • World
  • Pain Therapeutics
  • Clinical Trial profile. 350 Trial Title

The prominent features of this report are - ##.

  • Anti Rheumatic
  • Arthritis
  • Opioid
  • World
  • Pfizer Inc.

The prominent features of this report are - ##.

  • Clinical Trial
  • Drug Discovery And Development
  • Opioid
  • Pharmaceutical
  • World

Infliximab by Nippon Kayaku (approved in 2014) and Filgrastim by Teva Pharma Japan (approved in 2013) are some of the drugs of this segment.

  • Anti-Infective
  • Opioid
  • Japan
  • Meiji Seika Pharma Co., Ltd.
  • Nipro Corporation